Background/Aim: This study aimed to investigate the potential differences between multi-institutional measurements and treatment planning system (TPS) calculation modeled by representative beam data for patient-specific quality assurance (QA), including multi-leaf collimator (MLC) parameters. Materials and Methods: Eleven TrueBeam from nine institutions were used in this study. Volumetric arc therapy (VMAT) plan for verification was created using Eclipse. The point dose of the CC13 ionization chamber and the dose distribution of the GAFCHROMIC EBT3 film were measured and analyzed. Results: Point dose differences in patient-specific QA provided a mean±standard deviation of 1.0%±0.6%. Mean gamma pass rates of dose distribution were in excess of 99% and 96% for 3%/2 mm and 2%/2 mm gamma criteria, respectively. Conclusion: There was good agreement between measurements and calculations, indicating the small influence of complex VMAT in the underlying processes. Therefore, implementation of the same MLC parameters on TPS among different institutions with the same planning policy should be considered to ensure consistency and efficiency in radiation treatment processes.Novel radiotherapy devices are becoming increasingly accurate, and a prominent example involves TrueBeam (Varian Medical Systems, Inc., Palo Alto, CA) where the respective variance has become very narrow (1-4). Varian Medical Systems provide representative beam data (RBD) that is averaged beam data measured by three TrueBeam at the Duke University (1). It has been reported that the measured TrueBeam and the RBD data were very similar. Tanaka et al. (5) have reported that the averaged measurement data for treatment planning system (TPS) modeling indicated a small variance. More specifically, the percentage depth dose (PDD) difference between the RBD and the averaged measurement data was within 0.5%, whereas the off-center ratio (OCR) for a flat 10×10, 20×20, and 30×30 cm 2 region between the RBD and the averaged measurement data was within 1%.Multi-leaf collimator (MLC) systems enable the precise delivery of the intended dose according to planned dose constraints by complex MLC motion (6-9). The accuracy of the MLC position influences the intensity-modulated radiation therapy (IMRT) and the volumetric modulated arc therapy (VMAT) (10-12). Simultaneously, MLC parameters in TPS need to be modified to maintain consistency with patient-specific quality assurance (QA) measured data (11,13). In Eclipse (Varian Medical Systems), MLC parameters are controlled by the dosimetric leaf gap (DLG) and the transmission factor, which are not provided as RBD (14). Moreover, the optimum MLC parameters depend on the plan, delivery system, TPS, and tools used in patient-specific QA (12,13,15). Our previous report suggests that the variation between the optimum and the measured MLC parameters was significantly large because of the different clinical conditions in each institution, different types of cases, systems, TPS, and 1503 This article is freely accessible online.